Entinostat + Nivolumab Yields Durable Results in Some Pancreatic Cancer Patients
Primary end point not met, but small subset of advanced pancreatic ductal adenocarcinoma patients showed durable responses
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.